Qpex Biopharma

Omnix Medical

This biopharmaceutical company develops novel antibiotic agents for patients suffering from life-threatening, drug-resistant bacterial infections.

Calixa Therapeutics

This biopharmaceutical company develops novel antibiotics to treat serious infections caused by multi-drug-resistant pathogens for hospital patients.

SelectX Pharmaceuticals

This biopharmaceutical company develops small molecule antimicrobials and therapeutics for unmet medical needs using a genetic chemistry platform for patients with infectious diseases.

C10 PHARMA

This biopharmaceutical company develops novel antibiotics to treat life-threatening bacterial infections and combat antimicrobial resistance for patients with unmet medical needs.

Nabriva

This biopharmaceutical company develops and commercialises novel antibiotics for patients with serious infections caused by drug-resistant bacteria.

Acurx Pharmaceuticals

This biopharmaceutical company develops small molecule antibiotics to treat patients with bacterial infections caused by priority pathogens.

Spero

This biopharmaceutical company develops medicines for immune-mediated diseases and multi-drug resistant bacterial infections for patients with unmet medical needs.

Melinta Therapeutics

This biopharmaceutical company develops and commercialises antibiotics and antifungals to treat drug-resistant infections in hospital and clinic settings.